Sanghoo Lee

Dr. Sanghoo Lee


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Analytical Methods in Chemistry
Verified
Journal Article
Open access
PDF file
SLSanghoo Lee
Sanghoo Lee
HLHwan-Sub Lim
Hwan-Sub Lim
HSHye-Jin Shin
Hye-Jin Shin
SKSeol-A Kim
Seol-A Kim
JPJimyeong Park
Jimyeong Park
SLSanghoo Lee
Sanghoo Lee
A fast, sensitive, and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was validated and then the levels of cortisol and cortisone from sera of healthy adults were determined by the LC-MS/MS method. One hundredμL of serum sample was directly extracted by adding 2 mL ethyl acetate, followed by chromatographic separation on a C18 column with a mobile phase consisting of 5 mM ammonium acetate and methanol (25 : 75, v/v). The precision, accuracy, and average recovery of the method were 1.5–5.3%, 95.4–102.5%, and 96.4% for cortisol, and 1.9–6.0%, 89.2–98.8%, and 79.9% for cortisone, respectively. The method was linear from 1.0 to 500.0 ng/mLr2=0.999for cortisol and 2.5 to 100.0 ng/mLr2=0.998for cortisone. The limits of detection (LOD) and quantification (LOQ) were 0.2 and 1.0 ng/mL for cortisol, and 1.0 and 2.5 ng/mL for cortisone, respectively. The average cortisol concentration (133.9±63.7 ng/mL) of samples collected between 9:00 and 11:00 a.m. was higher approximately 4.4 times than that of cortisone (30.5±10.7 ng/mL)P<0.0001. The average cortisone/cortisol ratio was 0.225. Therefore, the LC-MS/MS method may be useful for the diagnosis of some adrenal diseases and the assessment of 11β-hydroxysteroid dehydrogenase (11β-HSD) activity in clinical laboratories.

23 August 2022 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
SLSanghoo Lee
Sanghoo Lee
SKSeol-A Kim
Seol-A Kim
JHJeonghoon Hong
Jeonghoon Hong
YKYejin Kim
Yejin Kim
GHGayeon Hong
Gayeon Hong
KLKyoung-Ryul Lee
Kyoung-Ryul Lee
Background: Metabolic syndrome (MetS) is a cluster of conditions associated with glucose intolerance, hypertension, abdominal obesity, dyslipidemia, and insulin resistance that increase the risk of cardiovascular diseases (CVD) and type 2 diabetes (T2D). Since MetS is known as a complex symptom with a high incidence of genetic factors, it is important to identify genetic variants for each clinical characteristic of MetS. Methods: We performed targeted next-generation sequencing (NGS) to identify genetic variants related to obesity, blood glucose, triacylglycerol (TG), and high-density lipoprotein (HDL)-cholesterol level, and hypertension in 48 subjects with MetS and in 48 healthy subjects. Results: NGS analysis revealed that 26 of 48 subjects (54.2%) with MetS had putative non-synonymous variants related to the clinical features of MetS. Of the subjects with MetS, 8 (16.7%) had variants in 4 genes (COL6A2, FTO, SPARC, and MTHFR) related to central obesity, 17 (35.4%) had variants in 6 genes (APOB, SLC2A2, LPA, ABCG5, ABCG8, and GCKR) related to hyperglycemia, 3 (6.3%) had variants in 4 genes (APOA1, APOC2, APOA4, and LMF1) related to hypertriglyceridemia, 8 (16.7%) had variants in 4 genes (ABCA1, CETP, SCARB1, and LDLR) related to low HDL-cholesterolemia, and 5 (10.4%) had variants in ADD1 related to hypertension. Conclusions: Our findings may contribute to broadening the genetic spectrum of risk variants related to the development of MetS.

11 January 2024 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MKMiRa Kim
MiRa Kim
MJMo Kyung Jung
Mo Kyung Jung
HJHye Mi Jee
Hye Mi Jee
EHEunkyo Ha
Eunkyo Ha
SLSanghoo Lee
Sanghoo Lee
EYEun-Gyong Yoo
Eun-Gyong Yoo

1 May 2021 in Virus Research
Verified
Journal Article
Closed access
SLSanghoo Lee
Sanghoo Lee
DWDongJu Won
DongJu Won
CKChang-Ki Kim
Chang-Ki Kim
JAJinwoo Ahn
Jinwoo Ahn
YLYoungkee Lee
Youngkee Lee
KLKyoung-Ryul Lee
Kyoung-Ryul Lee

22 August 2022 in Genes
Verified
Journal Article
Open access
PDF file
SLSanghoo Lee
Sanghoo Lee
SKSeol-A Kim
Seol-A Kim
YKYejin Kim
Yejin Kim
JKJuhoon Kim
Juhoon Kim
GHGayeon Hong
Gayeon Hong
KLKyoung-Ryul Lee
Kyoung-Ryul Lee
Metabolic syndrome (MetS) is a complex condition of metabolic disorders and shows a steady onset globally. Ceramides are known as intracellular signaling molecules that influence key metabolism through various pathways such as MetS and insulin resistance. Therefore, it is important to identify novel genetic factors related to increased plasma ceramides in subjects with MetS. Here we first measured plasma ceramides levels in 37 subjects with MetS and in 38 healthy subjects by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Specifically, levels of C16 ceramide (Cer-16), C18 ceramide (Cer-18), C20 ceramide (Cer-20), C18 dihydroceramide (DhCer-18), C24 dihydroceramide (DhCer-24), and C24:1 dihydroceramide (DhCer-24:1) were significantly increased in MetS group (p < 5.0 × 10−2). We then performed single nucleotide polymorphism (SNP) genotyping to identify variants associated with elevated plasma ceramides in MetS group using Axiom® Korea Biobank Array v1.1 chip. We also performed linear regression analysis on genetic variants involved in ceramide synthesis and significantly elevated plasma ceramides and dihydroceramides. Ten variants (rs75397325, rs4246316, rs80165332, rs62106618, rs12358192, rs11006229, rs10826014, rs149162405, rs6109681, and rs3906631) across six genes (ACER1, CERS3, CERS6, SGMS1, SPTLC2, and SPTLC3) functionally involved in ceramide biosynthesis showed significant associations with the elevated levels of at least one of the ceramide species in MetS group at a statistically significant threshold of false discovery rate (FDR)-adjusted p < 5.0 × 10−2. Our findings suggest that the variants may be genetic determinants associated with increased plasma ceramides in individuals with MetS.

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHye In Kim
Hye In Kim
ECEun A Choi
Eun A Choi
EPEun Chan Paik
Eun Chan Paik
SPSoohyeon Park
Soohyeon Park
YHYu Im Hwang
Yu Im Hwang
BYBo Hyon Yun
Bo Hyon Yun
Kim HI, et al. J Korean Med Sci. 2022 Nov;37(46):e336. https://doi.org/10.3346/jkms.2022.37.e336